Key Aspects of Analytical Development In-House Training
Key elements for a successful development of a drug product analytical development
The analytical aspects of the control strategy will be covered as well analytical documents for the submission.
Overview
The field of analytical development as part of the development of a new or generic drug product covers a huge range from the translation of the Quality Target Product Profile (QTPP) into the Analytical Target Profile (ATP) over the entire analytical procedure life cycle (i.e., development, validation, transfer, and maintenance of new analytical procedures) to key contribution to the control strategy of the commercial product (including definition of Critical Quality Attributes (CQAs), establishing of specification and justification for specification). In addition to these key elements for a successful development of a drug product analytical development is a key player in the stability studies and for the definition of the shelf-life of the medicinal product. Several regulatory documents are around analytical development which provide guidance to the key elements to this CMC topic such as the ICH guidelines for Pharmaceutical Development (Q8 (R2)), Analytical Development (Q14), Method Validation (Q2 (R2)), Specification (Q6A & Q6B), Impurities of new drug substances and products (Q3A & Q3B), and Stability testing (Q1A to Q1E). In addition, further scientific information can be found in pharmacopeial general chapters of the USP. These guidance documents form the basis of this in-house training around analytical development. In detail, the focus of this in-house training is on the specification of drug substances and products and it´s justification, determination of Critical Quality Attributes (CQAs), life cycle of analytical procedures, analytical documentation in terms of procedure content and validation / transfer of methods, and stability studies for drug substances and products. Furthermore, the analytical aspects of the control strategy will be covered as well analytical documents for the submission.
#inhouse #inhousetraining #glceurope #pharmainhousetraining #globalleadingconferences #keyaspects #analyticaldevelopment
RECOMMENDATION
Who should attend?
• Analytical Development
• Formulation Development
• Project Management
• Pre-clinical Development
• Clinical Development
• CMC Regulatory Affairs
• Quality Control
• Quality Assurance
• Drug Substance Manufacture
• Drug Product Manufacture
Testimonial
Our success stories
"High attention to detail in course content and very well delivered"
Simon Halsey
Product Development Manager
Essentra Packaging
United Kingdom
Our success stories
"Very good training led by two knowledgeable and open experts. Excellent insight given on many complex topics. Interactive and highly useful"
Aurelie Vivicorsi
USP PD Team Manager
Celonic AG
Switzerland
Our success stories
"Great course, impressed with the knowledge of the trainers and ability to answer wide variety of questions!"
Emilia Szwej
Manager, Senior Investigator
MT Sword Laboratories (BMS)
Germany
About GLC
Global Leadership Conferences began as an ambitious dream by three founders ten years ago. Today it’s an international series of interactive events, exploring the hottest topics in critical fields. Each year, thousands of professionals join us to challenge the status quo and learn innovative ways to create new solutions in Finance, Pharmaceutical, HR, Health & Safety, and Energy.
know more >12+
Years of experience
399
Events organized
3,710
Speakers
21,521
Attendees
Other events you may like
New ICH E6(R3) GCP Guideline MasterClass - US edition
29-30 April, 2024
Adoption of New Critical to Quality Requirements
learn more >>Leachables and Extractables MasterClass - US edition
06-07 May, 2024
Learn more about identification and control of Leachables and Extractables
learn more >>Process Validation for Biotechnological Products MasterClass - US edition
06-09 May, 2024
Understand how to qualify scale-down models
learn more >>